Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Nourish has completed the acquisition of Nourish, a healthcare services other business in California, for $100M. Nourish operates metabolic health clinics focused on diagnosing and managing metabolic disorders through clinical programs and ongoing patient care. The company’s services support personalized treatment pathways aimed at improving outcomes for patients with obesity, diabetes risk, and related conditions. The announced other acquisition follows a Series C funding round led by Menlo Ventures with participation from Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, and other investors, positioning Nourish to expand its metabolic health footprint and scale care delivery.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026